Why it matters:
Cancer patients are especially vulnerable to infections due to weakened immune systems from the disease and its treatments. These infections can be more severe and even life-threatening, making effective management essential for improved outcomes and quality of life.
The big picture:
The two-day seminar, held at the Espinas Palace Hotel in Tehran from February 20–21, 2025, brought together top researchers and clinicians. With Iran positioned as a leading country in cancer care, the event showcased groundbreaking strategies for preventing and managing infections in patients undergoing cancer therapies and organ transplants.
What he's saying:
Head of the Infectious Diseases Group at Shahid Beheshti University of Medical Sciences, Professor Masoud Mardani, explained that the seminar aimed to “revisit all aspects of infection in immunocompromised patients with a special focus on cancer and transplantation treatment.”
He emphasized that the latest developments in infection management for these high-risk groups were at the heart of the discussions.
Go deeper:
As Iran continues to host international experts and invest in advanced research, the future looks promising for even greater breakthroughs in the management of infections among cancer and transplant patients.
205
